Article
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
Thrombosis and haemostasis - 1 Jan 2016
De Stefano Valerio, Qi Xingshun, Betti Silvia, Rossi Elena
Abstract excerpt
Splanchnic vein thrombosis (SVT) encompasses Budd-Chiari syndrome (BCS), extrahepatic portal vein obstruction (EHPVO), and mesenteric vein thrombosis. Philadelphia-negative myeloproliferative neoplasms (MPNS) are the leading systemic cause of non-cirrhotic and non-malignant SVT and are diagnosed in 40% of BCS patients and one-third of EHPVO patients. In SVT patients the molecular marker JAK2 V617F is detectable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.